Literature DB >> 19358090

The low-dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insufficiency: Defining the normal cortisol response and report on first patients with Addison disease confirmed with LDT.

M Pura1, A Kreze, P Kentos, P Vanuga.   

Abstract

BACKGROUND: The validity of low-dose 1 microg cosyntropin test (LDT) is reported mainly for the assessment of secondary adrenocortical insufficiency (AI). Likewise the hypothalamic-pituitary disorders, early diagnosis of the initial or partial stages of primary AI has an important role.
OBJECTIVE: The aim of study was to: 1) establish the normal cut-off level at which the stimulated plasma cortisol (FP) in LDT excludes primary AI; 2) compare the results in elderly subjects to those in younger ones; 3) compare the results between normal and obese subjects; and 4) verify the established cut-off values on the sample of patients suspected to have primary AI. SUBJECTS AND METHODS: 110 subjects (99 women and 11 men, aged 19-80 years, mean 46.2+/-16.1 years, without suspicion for impairment of the hypothalamo-pituitary-adrenal axis were recruited to undergo the LDT in standard conditions. Control group consists of 30 patients (22 women and 8 men, aged 7-58 years, mean 38.4+/-10.6 years) evaluated in whom for suspicion of primary AI as suggested by LDT was confirmed by supplemental investigations (elevated ACTH levels, positive autoantibodies against 21-hydroxylase, mutational analysis of corresponding genes).
RESULTS: The mean peak FP level at 30 min (FP (30)) of the subjects was 675+/-85 nmol/L (95% CI=659 to 691 nmol/L), thus reference values expressed as mean+/-2 SD were 505-845 nmol/L. There was a significant negative correlation between basal FP values (FP (0)) (434+/-105 nmol/L) and the absolute FP incremental (FP (Delta)) response varying from 52 to 553 nmol/L (median 230 nmol/L) (r=-0.71; P<0.001). FP (30) was higher in elderly subjects (n=27) in comparison to younger subjects (n=25) (689+/-88 nmol/L vs. 642+/-63 nmol/L, u=2.11, P<0.05) due to higher FP (Delta) (274+/-116 nmol/L vs. 175+/-112 nmol/L; u=4.02, P<0.01) ; FP (30) levels in obese subjects (n=27) did not differ from those with normal BMI (n=33) (694+/-100 nmol/L vs. 667+/-65 nmol/L, u=1.31, P>0.05). We did not find any correlation between body weight or body surface area and FP (0), FP (30) or FP (Delta). Post-stimulation FP (30) levels in the control group varied from 0 to 354 nmol/L with median 64 nmol/L (25 (th) percentile 10 nmol/L; 75 (th) percentile 165 nmol/L) and were entirely distinctive from those of the subjects without adrenal impairment ( P<0.001).
CONCLUSIONS: Taking the mean -2 SD result as a threshold, FP value of 500 nmol/L can be consider as cut-off at 30 min in the LDT for defining the intact adrenocortical function, independently of age and body weight, body surface area. J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart * New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358090     DOI: 10.1055/s-0029-1202275

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  ACTH protects against glucocorticoid-induced osteonecrosis of bone.

Authors:  Mone Zaidi; Li Sun; Lisa J Robinson; Irina L Tourkova; Li Liu; Yujuan Wang; Ling-Ling Zhu; Xuan Liu; Jianhua Li; Yuanzhen Peng; Guozhe Yang; Xingming Shi; Alice Levine; Jameel Iqbal; Beatrice B Yaroslavskiy; Carlos Isales; Harry C Blair
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

2.  Comorbid Latent Adrenal Insufficiency with Autoimmune Thyroid Disease.

Authors:  Toshihide Yamamoto
Journal:  Eur Thyroid J       Date:  2015-06-25

3.  Accuracy of the Low-Dose ACTH Stimulation Test for Adrenal Insufficiency Diagnosis: A Re-Assessment of the Cut-Off Value.

Authors:  Laura Maria Mongioì; Rosita Angela Condorelli; Federica Barbagallo; Rossella Cannarella; Sandro La Vignera; Aldo Eugenio Calogero
Journal:  J Clin Med       Date:  2019-06-05       Impact factor: 4.241

4.  Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency.

Authors:  Worapaka Manosroi; Mattabhorn Phimphilai; Jiraporn Khorana; Pichitchai Atthakomol
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

5.  SIADH and hyponatraemia: why does it matter?

Authors:  Ewout J Hoorn; Nils van der Lubbe; Robert Zietse
Journal:  NDT Plus       Date:  2009-11

Review 6.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.